—

Redmile Group, LLC

Q1 2026 13F Holdings

  • Location
    larkspur, CA
  • Num holdings

    35

  • Value ($000)

    $1,510,149

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001425738
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
S
SRRK

SCHOLAR ROCK HLDG CORP

COM
80706P103
$445.72M
30 %

9,066,621

K
KRYS

KRYSTAL BIOTECH INC

COM
501147102
$173.98M
12 %

673,505

S
STOK

STOKE THERAPEUTICS INC

COM
86150R107
$135.58M
9 %

4,164,120

I
IMNM

IMMUNOME INC

COM
45257U108
$121.57M
8 %

5,558,885

N
NRIX

NURIX THERAPEUTICS INC

COM
67080M103
$119.86M
8 %

7,732,808

A
ANNX

ANNEXON INC

COM
03589W102
$80.61M
5 %

14,549,768

---

ADC THERAPEUTICS SA

SHS
H0036K147
$58.01M
4 %

15,470,502

R
RGNX

REGENXBIO INC

COM
75901B107
$36.61M
2 %

4,368,804

S
STTK

SHATTUCK LABS INC

COM
82024L103
$35.62M
2 %

5,539,724

B
BEAM

BEAM THERAPEUTICS INC

COM
07373V105
$29.49M
2 %

1,237,659

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 35